Hypersensitivity reaction to desipramine

Panuska, James R.; King, Thomas; Korenblat, P.E.; Wedner, H. James

doi:10.1016/s0091-6749(87)80185-9

Cited by 16 publications

(1 citation statement)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Pulmonary fibrosis is a well recognized complication of some relatively rarely used drugs such as amiodarone or cytotoxic agents, 33 but in clinical practice exposure to these agents would normally be identified in the course of a standard clinical history and the potential causal association in an individual patient thus identified. However pulmonary fibrosis has also been reported as a rare complication of some much more commonly used drugs, including antidepressants, 34–37 antibiotics, 38–41 beta blockers, 42–45 anticonvulsants 46,47 and nonsteroidal anti‐inflammatory drugs (NSAIDs) 48–52 . It is therefore possible that CFA may to some extent be attributable to a rare complication of these widely used drugs.…”

Section: Drug Exposuresmentioning

confidence: 99%

Recent advances in the aetiology of cryptogenic fibrosing alveolitis

Britton

Hubbard

2000

Histopathology

View full text Add to dashboard Cite

Crytogenic fibrosing alveolitis is the commonest intersititial lung disease but, until recently, very little has been known about its aetiology. The histopathologist usually sees this disease at transbronchial biopsy or at autopsy. This article reviews the current knowledge of the aetiology of cryptogenic fibrosing alveolitis looking at possible infective, occupational, drug-related, smoking-associated, genetic and dietary factors. Knowledge of the possible roles of these factors in the disease process informs histopathologists when they are reporting these biopsies and enables them to make a larger contribution to defining the pathogenetic mechanisms.

show abstract